Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Venture Global Inc. Class A common stock (VG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Venture Global Inc. Class A common stock — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.62 (market cap $25.27B), while Venture Global Inc. Class A common stock trades at $13.13 (market cap $33.23B). The key difference: Venture Global Inc. Class A common stock is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Venture Global Inc. Class A common stock for 0 Days on average.
| RPRX | VG | |
|---|---|---|
Market Cap | $25.27B | $33.23B |
Volume | 3,671,183 | 12,625,066 |
Sector | Health | Energy |
52-Week High | $63.96 | $17.53 |
52-Week Low | $35.44 | $5.92 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $32.50B | $72.61B |
Dividend Yield | 1.66% | 1.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Venture Global Inc. Class A common stock
Venture Global develops, builds, and operates liquefied natural gas export facilities. Its projects connect U.S. natural gas supply with global LNG markets.
Read more on VG →
